St. Anna Hospital, 2nd Internal Department
About St. Anna Hospital, 2nd Internal Department
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Ipsen
1
Lyra Therapeutics
1
Neurobiological Technologies
1
Sygnis Bioscience GmbH & Co KG
1
Clinical Trials at St. Anna Hospital, 2nd Internal Department
During the past decade, St. Anna Hospital, 2nd Internal Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
2005-09-01
2008-12-01
Terminated
277
Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis
2003-02-01
2005-03-01
Completed
138
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
2008-12-03
2017-11-13
Completed
1,314
This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)
2017-10-17
2019-12-10
Completed
75
LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)
2019-05-09
2021-02-04
Completed
71
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "St. Anna Hospital, 2nd Internal Department" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Ipsen" with 1 trials
sponsored, "Lyra Therapeutics" with 1 trials sponsored, "Neurobiological Technologies" with 1 trials sponsored and "Sygnis Bioscience GmbH & Co KG"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at St. Anna Hospital, 2nd Internal Department
According to Clinical.Site data, the most researched conditions in "St. Anna Hospital, 2nd Internal Department" are
"Acute Ischemic Stroke" (1 trials), "Brain Infarction" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Cerebral Ischemia" (1 trials) and "Chronic Rhinosinusitis (Diagnosis)" (1 trials). Many other conditions were trialed in "St. Anna Hospital, 2nd Internal Department" in a lesser frequency.
Clinical Trials Intervention Types at St. Anna Hospital, 2nd Internal Department
Most popular intervention types in "St. Anna Hospital, 2nd Internal Department" are "Drug" (5 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Ancrod (Viprinex)" (1 trials), "BI 685509" (1 trials), "BIBF 1120 plus docetaxel" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St. Anna Hospital, 2nd Internal Department
The vast majority of trials in "St. Anna Hospital, 2nd Internal Department" are
6 trials for "All" genders.
Clinical Trials Status at St. Anna Hospital, 2nd Internal Department
Currently, there are NaN active trials in "St. Anna Hospital, 2nd Internal Department".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in St. Anna Hospital, 2nd Internal Department,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in St. Anna Hospital, 2nd Internal Department, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".